| 000 | 01640 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513060355.0 | ||
| 264 | 0 | _c19940929 | |
| 008 | 199409s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/BF00192549 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRimoy, G H | |
| 245 | 0 | 0 |
_aThe cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _c1994 |
||
| 300 |
_a203-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCentral Nervous System Agents _xpharmacology |
| 650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
| 650 | 0 | 4 |
_aDiuretics _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xpharmacology |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNaloxone _xpharmacology |
| 650 | 0 | 4 |
_aNorepinephrine _xblood |
| 650 | 0 | 4 | _aPsychometrics |
| 650 | 0 | 4 |
_aPulse _xdrug effects |
| 650 | 0 | 4 |
_aPyrrolidines _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Opioid, kappa _xdrug effects |
| 700 | 1 | _aWright, D M | |
| 700 | 1 | _aBhaskar, N K | |
| 700 | 1 | _aRubin, P C | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 46 _gno. 3 _gp. 203-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00192549 _zAvailable from publisher's website |
| 999 |
_c8069825 _d8069825 |
||